We describe a 3-year-old child with mollusca contagiosa whose caregiver applied a eutectic mixture of 5% lidocaine and prilocaine (EMLA) in excessive amounts with the subsequent development of adverse reactions, including methemoglobinemia and hypoxemia. Because of the significant systemic absorption of lidocaine and prilocaine, the patient required overnight admission to the pediatric intensive care unit for close monitoring. A brief description of the proper dosing, pharmacokenetics, and possible side effects of EMLA cream are reviewed. (J Am Acad Dermatol 2001;44:399-400.)Le texte complet de cet article est disponible en PDF.
| This supplement is made possible through an educational grant from Ortho Dermatological to the American Academy of Dermatology.
| Reprint requests: Susan Touma, MD, 4 McBride Rd, Canonsburg, PA 15317.
| J Am Acad Dermatol 2001;44:399-400